| Literature DB >> 19552203 |
Adrien A Eshraghi1, Bruno Frachet, Tom R Van De Water, Elias Eter.
Abstract
The management of hearing loss in adults depends of etiology and its severity. It can be as simple as treating an external otitis, removing an impacted cerumen or a more complex one such as a surgery for otosclerosis. The hearing loss is managed mainly by new advances in hearing aids technology and implantable hearing devices which include BAHA, middle ear implant and cochlear implants. The research is focused on developing new molecules for intracochlear drug therapy to treat noise induced hearing loss, drug ototoxicity as well as hearing loss related to cochlear implant insertion trauma. Antioxidant molecules, molecules against apoptosis are at this time the most promising molecules than need further investigations.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19552203
Source DB: PubMed Journal: Rev Prat ISSN: 0035-2640